Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects
Clinical trial NCT05106205 · COMPLETED
Trial details
- NCT number
- NCT05106205
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2022-01-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.